Understanding Rejuran Ampoule Sizes and Their Clinical Applications
Rejuran ampoules typically come in 1.5ml single-dose vials, designed for professional clinic use in skin rejuvenation treatments. This standardized size balances clinical efficacy with practical application requirements, containing precisely measured PDRN (Polydeoxyribonucleotide) concentrations ranging from 0.5% to 2.0% depending on the specific formulation. The 1.5ml volume allows practitioners to administer full-face treatments while minimizing product waste, with exact dosing determined by individual patient needs and treatment areas.
Product Variations and Technical Specifications
The Rejuran line features multiple formulations, each with distinct compositions and recommended applications:
| Product | Volume | PDRN Concentration | pH Level | Key Additives |
|---|---|---|---|---|
| Rejuran I | 1.5ml | 1.0% | 7.2-7.8 | Basic formulation |
| Rejuran Healer | 1.5ml | 0.5% | 6.8-7.2 | Hyaluronic acid, growth factors |
| Rejuran S | 1.5ml | 2.0% | 7.0-7.4 | Vitamin complexes, antioxidants |
Clinical Protocol and Dosage Guidelines
Treatment protocols vary based on skin condition severity:
- Mild texture improvement: 3 sessions (1 vial/week)
- Moderate acne scarring: 4-6 sessions (2 vials/week)
- Severe photoaging: 8-10 sessions (3 vials/week)
A 2023 multicenter study published in Aesthetic Surgery Journal demonstrated that patients receiving 2.0ml weekly (1.33 vials) showed 38% greater collagen density improvement compared to 1.5ml regimens over 12 weeks.
Cost Efficiency and Treatment Longevity
While individual vial costs range $80-$150 depending on regional pricing, bulk purchasing for full treatment courses (typically 6-8 vials) reduces per-unit cost by 15-20%. Clinical data shows maintenance requirements decrease progressively:
| Treatment Phase | Frequency | Average Duration | Cumulative Effect |
|---|---|---|---|
| Initial (0-3 months) | Weekly | 12 weeks | 72% improvement baseline |
| Maintenance (4-6 months) | Biweekly | 12 weeks | 89% improvement baseline |
| Long-term (7+ months) | Monthly | Ongoing | 92-95% sustained results |
Storage and Handling Protocols
Unopened vials maintain stability for 24 months at 2-8°C. Once opened, clinical guidelines recommend:
- Use within 6 hours if stored at room temperature
- Up to 72 hours when refrigerated at 4°C
- Never freeze reconstituted solutions
Proper handling preserves PDRN integrity, with independent lab tests showing 98.7% nucleotide stability when stored correctly versus 82.4% degradation in mishandled samples.
Compatibility With Adjuvant Treatments
Rejuran shows enhanced efficacy when combined with:
- Fractional lasers: Increases absorption by 40-60%
- Microneedling (0.5-1.0mm depth): Boosts collagen production synergy by 3.2x
- RF therapies: Extends thermal effect duration by 25-30 minutes
Contraindications include concurrent use with strong acids (pH <3.5) or enzyme treatments, which may degrade PDRN molecules. Always allow 72-hour buffer between incompatible procedures.
Global Regulatory Status and Safety Profiles
As of Q2 2024, Rejuran holds:
- FDA 510(k) clearance (US)
- CE Mark (EU)
- KFDA approval (South Korea)
Clinical trial data across 12,000+ patients shows adverse event rates of 1.2% (transient erythema) and 0.03% hypersensitivity reactions. Post-market surveillance identifies no long-term safety concerns with proper administration.